Pharmaids Pharmaceuticals Ltd — Insider Trading, 30-09-2025: Insider Trading / SAST

Pharmaids Pharmaceuticals has announced the closure of its trading window for designated persons and their immediate relatives. This closure begins from the start of October and will remain in effect until 48 hours after the company declares its financial results for the quarter and half-year. The decision ensures fair trading practices before these financial results are made public. The date for the Board Meeting to consider these results will be announced subsequently. This is a standard measure to prevent insider trading and maintain market integrity for shareholders.